MedTrace Logo

Mepivacaine vs. Bupivacaine Spinal Anesthetic in Total Knee Arthroplasty

NCT02980926 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2017-03-27

No results posted yet for this study

Summary

The purpose of this study is to determine if a shorter-acting spinal anesthetic called mepivacaine has advantages over a longer-acting medication called bupivacaine.

Conditions

  • Anesthesia, Spinal
  • Arthroplasty, Replacement, Knee
  • Pain Management
  • Early Ambulation
  • Ambulatory Surgical Procedures

Interventions

DRUG

Mepivacaine

This is a shorter acting spinal anesthetic as compared to the current standard of care at this institution.

DRUG

Bupivacaine

This is the current standard of care at this institution and many centers. This is a longer acting spinal anesthetic compared to the study drug.

Sponsors & Collaborators

  • Henry Ford Health System

    lead OTHER

Principal Investigators

  • Jason Davis, MD · Surgeon

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2017-03-31
Completion
2017-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02980926 on ClinicalTrials.gov